Amy Manning-Bog is an accomplished scientific professional with extensive experience in biotechnology and pharmaceutical development. Currently serving as Chief Scientific Officer at Ronawk and Founder of Stealth Mode Biotech since late 2024, Manning-Bog previously held key leadership positions including Chief Innovation Officer at MRIGlobal and Vice President roles at Atreca, Inc. spanning various aspects of drug discovery and translational sciences. Early career experiences include significant roles at Sangamo BioSciences, SRI International, and The Parkinson's Institute, as well as academic positions as Adjunct Faculty at UC Santa Cruz and The Parkinson's Institute. Manning-Bog earned an Interdisciplinary PhD in Biochemistry and Molecular Biology from the University of Missouri-Kansas City and a Bachelor of Science in Biology from Missouri State University.
This person is not in any teams
This person is not in any offices